JERUSALEM (Legal Newsline) — Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic medications, announced Thursday that its U.S. subsidiary has entered into a settlement with Pfizer Inc. over Teva’s generic version of Celebrex.

Specifically, Teva Pharmaceuticals USA Inc.’s settlement with Pfizer — one of the world’s largest pharmaceutical companies — covers celecoxib 50, 100, 200 and 400 mg capsules in the United States.